These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 35242284)

  • 1. How fullerene derivatives (FDs) act on therapeutically important targets associated with diabetic diseases.
    Fjodorova N; Novič M; Venko K; Drgan V; Rasulev B; Türker Saçan M; Sağ Erdem S; Tugcu G; Toropova AP; Toropov AA
    Comput Struct Biotechnol J; 2022; 20():913-924. PubMed ID: 35242284
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cheminformatics and Machine Learning Approaches to Assess Aquatic Toxicity Profiles of Fullerene Derivatives.
    Fjodorova N; Novič M; Venko K; Rasulev B; Türker Saçan M; Tugcu G; Sağ Erdem S; Toropova AP; Toropov AA
    Int J Mol Sci; 2023 Sep; 24(18):. PubMed ID: 37762462
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A Comprehensive Cheminformatics Analysis of Structural Features Affecting the Binding Activity of Fullerene Derivatives.
    Fjodorova N; Novič M; Venko K; Rasulev B
    Nanomaterials (Basel); 2020 Jan; 10(1):. PubMed ID: 31906497
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Nanoparticle Fullerene (C60) demonstrated stable binding with antibacterial potential towards probable targets of drug resistant Salmonella typhi - a computational perspective and in vitro investigation.
    Skariyachan S; Parveen A; Garka S
    J Biomol Struct Dyn; 2017 Dec; 35(16):3449-3468. PubMed ID: 27817242
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Editorial: Current status and perspective on drug targets in tubercle bacilli and drug design of antituberculous agents based on structure-activity relationship.
    Tomioka H
    Curr Pharm Des; 2014; 20(27):4305-6. PubMed ID: 24245755
    [TBL] [Abstract][Full Text] [Related]  

  • 6. 3D MI-DRAGON: new model for the reconstruction of US FDA drug- target network and theoretical-experimental studies of inhibitors of rasagiline derivatives for AChE.
    Prado-Prado F; García-Mera X; Escobar M; Alonso N; Caamaño O; Yañez M; González-Díaz H
    Curr Top Med Chem; 2012; 12(16):1843-65. PubMed ID: 23030618
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Identification and Ranking of Core Values in Family Medicine: A Mixed Methods Study From Ukraine.
    Kolesnyk P; Bayen S; Shushman I; Kolesnyk A; Kuodza G; Klemenc-Ketiš Z; Frese T
    Front Med (Lausanne); 2021; 8():646276. PubMed ID: 33829026
    [No Abstract]   [Full Text] [Related]  

  • 8. Carbon fullerene acts as potential lead molecule against prospective molecular targets of biofilm-producing multidrug-resistant
    Skariyachan S; Gopal D; Kadam SP; Muddebihalkar AG; Uttarkar A; Niranjan V
    J Biomol Struct Dyn; 2021 Feb; 39(3):1121-1137. PubMed ID: 32036742
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Targeting HIV/HCV Coinfection Using a Machine Learning-Based Multiple Quantitative Structure-Activity Relationships (Multiple QSAR) Method.
    Wei Y; Li W; Du T; Hong Z; Lin J
    Int J Mol Sci; 2019 Jul; 20(14):. PubMed ID: 31336592
    [TBL] [Abstract][Full Text] [Related]  

  • 10. In silico approaches: prediction of biological targets for fullerene derivatives.
    Gupta SK; Dhawan A; Shanker R
    J Biomed Nanotechnol; 2011 Feb; 7(1):91-2. PubMed ID: 21485819
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Computational design of novel fullerene analogues as potential HIV-1 PR inhibitors: Analysis of the binding interactions between fullerene inhibitors and HIV-1 PR residues using 3D QSAR, molecular docking and molecular dynamics simulations.
    Durdagi S; Mavromoustakos T; Chronakis N; Papadopoulos MG
    Bioorg Med Chem; 2008 Dec; 16(23):9957-74. PubMed ID: 18996019
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Inhibitors or toxins? Large library target-specific screening of fullerene-based nanoparticles for drug design purpose.
    Ahmed L; Rasulev B; Kar S; Krupa P; Mozolewska MA; Leszczynski J
    Nanoscale; 2017 Jul; 9(29):10263-10276. PubMed ID: 28696446
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Application of GA-MLR for QSAR Modeling of the Arylthioindole Class of Tubulin Polymerization Inhibitors as Anticancer Agents.
    Ahmadi S; Habibpour E
    Anticancer Agents Med Chem; 2017; 17(4):552-565. PubMed ID: 27528182
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Boosted neural networks scoring functions for accurate ligand docking and ranking.
    Ashtawy HM; Mahapatra NR
    J Bioinform Comput Biol; 2018 Apr; 16(2):1850004. PubMed ID: 29495922
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Identification of potential descriptors of water-soluble fullerene derivatives responsible for antitumor effects on lung cancer cells via QSAR analysis.
    Huang HJ; Chetyrkina M; Wong CW; Kraevaya OA; Zhilenkov AV; Voronov II; Wang PH; Troshin PA; Hsu SH
    Comput Struct Biotechnol J; 2021; 19():812-825. PubMed ID: 33598097
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Consensus QSAR modeling of toxicity of pharmaceuticals to different aquatic organisms: Ranking and prioritization of the DrugBank database compounds.
    Khan K; Benfenati E; Roy K
    Ecotoxicol Environ Saf; 2019 Jan; 168():287-297. PubMed ID: 30390527
    [TBL] [Abstract][Full Text] [Related]  

  • 17. PDTD: a web-accessible protein database for drug target identification.
    Gao Z; Li H; Zhang H; Liu X; Kang L; Luo X; Zhu W; Chen K; Wang X; Jiang H
    BMC Bioinformatics; 2008 Feb; 9():104. PubMed ID: 18282303
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Receptor- and ligand-based study of fullerene analogues: comprehensive computational approach including quantum-chemical, QSAR and molecular docking simulations.
    Ahmed L; Rasulev B; Turabekova M; Leszczynska D; Leszczynski J
    Org Biomol Chem; 2013 Sep; 11(35):5798-808. PubMed ID: 23900343
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Macromolecular crowding: chemistry and physics meet biology (Ascona, Switzerland, 10-14 June 2012).
    Foffi G; Pastore A; Piazza F; Temussi PA
    Phys Biol; 2013 Aug; 10(4):040301. PubMed ID: 23912807
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Molecular Docking, G-QSAR Studies, Synthesis and Anticancer Screening of Some New 2-Phenazinamines as Bcr-Abl Tyrosine Kinase Inhibitors.
    Kale MA; Sonwane GM
    Curr Drug Discov Technol; 2020; 17(2):213-224. PubMed ID: 30210004
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.